Palvella Therapeutics (PVLA) Current Leases (2021 - 2026)

Palvella Therapeutics (PVLA) has 5 years of Current Leases data on file, last reported at $209000.0 in Q1 2026.

• On a quarterly basis, Current Leases changed N/A year-over-year to $209000.0 in Q1 2026; TTM through Mar 2026 was $209000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $202000.0, changed N/A from the prior year.
• Current Leases for Q1 2026 stood at $209000.0, up from $202000.0 in the prior quarter.
• Over the last five years, Current Leases for PVLA reached as high as $12.3 million in Q3 2023 and fell as low as $202000.0 in Q4 2025.
• Historically, Current Leases has averaged $2.3 million across 4 years, with a median of $859000.0 in 2022.
• Across the five-year window, Current Leases slipped 18.11% in 2022 and soared 1388.14% in 2023, its largest moves.
• Year by year, Current Leases stood at $859000.0 in 2022, then surged by 1330.97% to $12.3 million in 2023, then slumped by 98.36% to $202000.0 in 2025, then increased by 3.47% to $209000.0 in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $209000.0 in Q1 2026, $202000.0 in Q4 2025, and $12.3 million in Q3 2023.